EVOK - Evoke Pharma, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 5.47M
Enterprise value 751.29k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.05
Price/book (mrq)1.34
Enterprise value/revenue 0.26
Enterprise value/EBITDA -0.10

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-39.86%
S&P500 52-week change 30.07%
52-week high 35.9600
52-week low 31.3720
50-day moving average 32.0087
200-day moving average 32.3950

Share statistics

Avg vol (3-month) 318.19k
Avg vol (10-day) 322.5k
Shares outstanding 53.34M
Implied shares outstanding 6N/A
Float 83.26M
% held by insiders 12.46%
% held by institutions 11.83%
Shares short (14 May 2023) 426.12k
Short ratio (14 May 2023) 41.36
Short % of float (14 May 2023) 40.80%
Short % of shares outstanding (14 May 2023) 40.78%
Shares short (prior month 13 Apr 2023) 411.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 322 May 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -285.92%
Operating margin (ttm)-272.01%

Management effectiveness

Return on assets (ttm)-51.73%
Return on equity (ttm)-408.53%

Income statement

Revenue (ttm)2.9M
Revenue per share (ttm)0.88
Quarterly revenue growth (yoy)93.70%
Gross profit (ttm)2.14M
Net income avi to common (ttm)-8.29M
Diluted EPS (ttm)-2.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.21M
Total cash per share (mrq)2.46
Total debt (mrq)5.09M
Total debt/equity (mrq)239.46
Current ratio (mrq)5.93
Book value per share (mrq)0.64

Cash flow statement

Operating cash flow (ttm)-6.61M
Levered free cash flow (ttm)-4.06M